$90.02
+1.03 (+1.16%)
At Close: Jun 03, 2026
Biotech Innovations Remain At Forefront
11:10am, Friday, 16'th Apr 2021
The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively r
Moving Beyond COVID In Biopharma
09:31am, Thursday, 15'th Apr 2021
Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12,
Biotech ETFs Make Gains Tuesday, Despite the J&J Vaccine Pause
05:55pm, Tuesday, 13'th Apr 2021
Some biotech and pharmaceutical ETFs are gaining on Tuesday despite news that Johnson and Johnson's coronavirus vaccine has been halted in over two dozen states, after the Food and Drug Administratio
ETFs to Shine on Pfizer's Impressive COVID-19 Vaccine Update
06:12pm, Wednesday, 31'st Mar 2021
Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in coronavirus vaccine development as the outbreak worsens.
The Diana Ross 'Upside Down' Stock Market
01:20pm, Thursday, 04'th Mar 2021
Hedge Funds are using AAPL and FAANG as a "source of funds" What's working, not working, and what's next?
Healthcare: A Wide Choice Of Large And Well-Established Companies
02:41am, Friday, 19'th Feb 2021
The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets
Pharma ETFs in Focus Post Q4 Earnings
01:38pm, Friday, 05'th Feb 2021
Healthcare Q4 results seem robust given that it is the fourth-best sector from a revenue growth look and the sixth-strongest in terms of earnings growth.
Craving Healthcare: A Beginner's Guide And My 7 Picks
12:00pm, Friday, 31'st Jul 2020
The Healthcare sector has significantly outperformed the S&P500 in the last decade and with lower volatility – the only sector to do so.
The Reopening Killed The V-Shaped Recovery
07:43am, Monday, 29'th Jun 2020
This is a weekly series focused on analyzing the previous week’s economic data releases. The objective is to concentrate on leading indicators of economic activ
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?
12:00am, Monday, 04'th May 2020Advisory Alpha LLC Has $104,000 Position in iShares US Pharmaceuticals ETF (NYSEARCA:IHE)
08:20am, Saturday, 02'nd May 2020
Advisory Alpha LLC raised its holdings in iShares US Pharmaceuticals ETF (NYSEARCA:IHE) by 93.3% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commi
Centaurus Financial Inc. Acquires Shares of 800 iShares US Pharmaceuticals ETF (NYSEARCA:IHE)
08:26am, Saturday, 25'th Apr 2020
Centaurus Financial Inc. acquired a new stake in shares of iShares US Pharmaceuticals ETF (NYSEARCA:IHE) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchan
Healthcare & Biotech ETFs Digest GILD's Failure News: 5 Winners
06:30pm, Friday, 24'th Apr 2020
Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.
JNJ Beats, Cuts View on Coronavirus: Healthcare ETFs in Focus
02:15pm, Wednesday, 15'th Apr 2020
Investors should closely watch the movement of the stock and keep a close eye on ETFs having double-digit allocation to this diversified drug maker post its earnings release.
Sign In
Buy IHE